The United States is facing an unprecedented drug shortage crisis, with a record 323 active shortages at the start of 2024 — ...
How a small Peninsula company hopes to soothe the dangerously insatiable appetites of people with a rare neurological ...
Martin Lehr, co-founder and CEO of Context, said CT-95 generated “compelling” preclinical data while under development by ...
The consolidation of pharmacies and health insurance companies through years of dealmaking has led to a handful of pharmacy ...
The Food and Drug Administration just approved pharmaceutical company Eli Lilly’s Alzheimer’s drug donanemab, following a ...
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today ...
Learn about the benefits of Kisunla, the newly approved Alzheimer's drug that can modestly slow disease progression in the ...
The U.S. Food and Drug Administration on Tuesday approved another drug that slows cognitive and functional decline in people ...
U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that ...
Doctors have a new drug to prescribe to treat Alzheimer’s disease. Earlier this month, the U.S. Food and Drug Administration ...
The U.S. Food and Drug Administration said on Tuesday it would revoke the regulation that authorized the use of brominated ...
Veterans and bipartisan members of Congress are calling on the FDA to approve MDMA-assisted therapy as a new treatment for PTSD.